Podcast: Play in new window | Download (Duration: 58:00 — 39.8MB) | Embed
Diabetes drugs known as GLP-1 agonists, like Ozempic, are riding a wave of popularity right now. But the high cost and short supply because of their popularity as a weight loss remedy are putting the drugs out of reach for those who need them. Native Americans struggle with diabetes disproportionately. Now, is there a disparity when it comes to viable treatments?
GUESTS
Dr. Matthew Clark, chief medical officer for the Alaska Area Native Health Service and chair of the IHS National Pharmacy and Therapeutics Committee
Tarah Nelson, post-doctoral researcher at the University of Florida
Jason Hale (Prairie Band Potawatomi), senior research scientist and director for Indigenous community engagement with the Institute for Indigenous Studies at Lehigh University
Break 1 Music: Dancin’ on the Run (song) Inez Jasper (artist) Burn Me Down
Break 2 Music: Laugh Out Loud (song) Hataałii (artist) Singing into Darkness (album)